Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Worldwide Clinical Trials has selected Medidata Payments Cloud to streamline accurate, timely payments on behalf of their clinical trial sponsors.
read more
Mayne Pharma and Metrics Contract Services, have designated their new stability storage facility a “Center of Excellence.”
read more
Protea Biosciences announced it has integrated its therapeutic antibody analytical methods with new software developed by its partner, Protein Metrics.
read more
LabCorp and Novant Health have agreed to a multi-year extension of their Technical Services Agreement.
read more
For the requirements of molecular biology, genomic and forensic research facilities, Thermo Scientific’s new universal containers are specifically lot tested and certified to be free from RNase, DNase, human DNA and pyrogens.
read more
PAREXEL announced the CEO Roundtable on Cancer has again named PAREXEL a CEO Cancer Gold Standard employer.
read more
Medicure announced it and Mauritius have exercised their option to acquire additional interests in Apicore Inc. and Apicore LLC from Apicore's founding shareholders.
read more
AmerisourceBergen has become the first pharmaceutical 3PL provider to achieve certification under the ISO 9001:2015 standards.
read more
Eurofins Scientific has signed an exclusive agreement with Ekkio Capital to acquire the Amatsigroup for a price of approximately EUR 130m plus some residual debt at closing.
read more
Arsenal Capital Partners has agreed to sell its portfolio company, Certara to EQT VII Fund for an enterprise value of $850 million.
read more
SQI Diagnostics announced the sale of a Sqid-X system under the terms of an agreement with IRX Therapeutics.
read more
Thermo Fisher Scientific announced the results of a collaboration agreement to enable researchers to combine the results of high-resolution Orbitrap LC/MS experiments with highly curated and organism-specific metabolic pathway and genome data for ...
read more
J. David Enloe, Jr., CEO of Ajinomoto Althea was awarded Most Admired CEO in 2017 by the San Diego Business Journal.
read more
Genentech has commenced a Phase 1b/2 study for BL-8040 in combination with atezolizumab (TECENTRIQ).
read more
Quanticate has completed an investment initiative to upgrade its pharmacovigilance safety database and its in-house technology platform.
read more